Medical Annals

The Importance of Transplant Testing

Transplant testing plays a vital role in improving outcomes for patients undergoing bone marrow or stem cell transplants. Eurofins offers comprehensive pre- and post-transplant testing, including advanced HLA typing, infectious disease monitoring, and graft-versus-host disease (GVHD) detection. These services enable healthcare providers to optimize patient care by minimizing complications such as graft rejection and infections. With cutting-edge diagnostics and personalized testing solutions, Eurofins Viracor is committed to enhancing transplant success and supporting patients and healthcare teams.

Leading the Way in Pediatric Cancer Testing

Eurofins Viracor is innovating in the area of pediatric cancer testing, offering advanced diagnostics to improve outcomes for children with leukemia. The ExPeCT^TM CAR T test provides essential monitoring of CAR T-cell therapy, allowing clinicians to assess treatment response, predict relapse, and optimize care. This non-invasive test enhances personalized treatment, leading to better outcomes and prolonged survival for young patients. Eurofins Viracor remains committed to advancing pediatric cancer diagnostics and improving care for children battling leukemia.

Comprehensive CMV Testing: Assessing, Treating, and Managing Cytomegalovirus

Cytomegalovirus (CMV) is a widespread virus that can have severe impacts on immunocompromised individuals, pregnant women, and newborns. Early detection is key to managing CMV, and we offer comprehensive testing solutions including serological, molecular, and viral load testing. These diagnostics help assess exposure, monitor disease progression, and guide treatment for improved patient outcomes. With tailored testing and early intervention, healthcare providers can effectively manage CMV infections and minimize complications in high-risk populations.

Invasive Fungal Diseases

Invasive fungal diseases (IFDs) pose a serious threat to immunocompromised individuals, such as those with HIV/AIDS, cancer, or organ transplants. Early diagnosis and prompt treatment are essential in managing these infections and improving patient outcomes. We offer a range of diagnostic tools, including culture, antigen, and molecular tests, to identify fungal pathogens and guide therapy. With comprehensive testing and therapeutic drug monitoring for antifungals like azoles, healthcare providers can better manage IFDs and reduce complications. Prevention measures and early intervention play a key role in mitigating risks.

Exploring the History and Future of CAR T-cell Therapy and Eurofins Viracor Testing

CAR T-cell therapy is a groundbreaking cancer treatment that involves genetically modifying a patient's T-cells to target and destroy cancer cells. Initially used for blood cancers like leukemia and lymphoma, it has expanded to other cancers with significant success. Eurofins Viracor supports this therapy with its ExPeCT™ anti-CD19 CAR T-cell assay, which monitors the expansion and persistence of CAR T-cells, optimizing patient outcomes and ensuring safety. As research advances, CAR T-cell therapy continues to offer promising potential for more widespread cancer treatment.

Resource Center Search